Cargando…

Letter to the Editor Regarding Combination of Tocilizumab and Steroids to Improve Mortality in Patients with Severe COVID-19 Infection: A Spanish, Multicenter, Cohort Study

Detalles Bibliográficos
Autores principales:	Janapala, Rajesh Naidu, Patel, Jigar, Belfaqeeh, Omar, Alhashmi, Abdulla, Pourmand, Ali
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2021
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8083090/ https://www.ncbi.nlm.nih.gov/pubmed/33914266 http://dx.doi.org/10.1007/s40121-021-00443-5

Ejemplares similares

Organizational characteristics: Effect on outcome of ICU COVID-19 patients in Belgium
por: Patel, Jigar, et al.
Publicado: (2021)

Novaferon, treatment in COVID-19 patients
por: Janapala, Rajesh Naidu, et al.
Publicado: (2021)

Clinical outcomes of patients with mild COVID-19 following treatment with hydroxychloroquine in an outpatient setting
por: Janapala, Rajesh Naidu, et al.
Publicado: (2021)

COVID-19: could CT provide the best population level biomarker? Incidental COVID-19 in major trauma patients suggests higher than predicted rates of infection in London
por: Alhashmi, A., et al.
Publicado: (2021)

Azithromycin, a questionable treatment for COVID-19
por: Belfaqeeh, O., et al.
Publicado: (2021)

A Response to: Letter to the Editor Regarding Combination of Tocilizumab and Steroids to Improve Mortality in Patients with Severe COVID-19 Infection: A Spanish, Multicenter, Cohort
por: Ruiz-Antorán, Belén, et al.
Publicado: (2021)

Therapeutic anticoagulation in COVID-19 patients
por: Belfaqeeh, O., et al.
Publicado: (2021)

Combination of Tocilizumab and Steroids to Improve Mortality in Patients with Severe COVID-19 Infection: A Spanish, Multicenter, Cohort Study
por: Ruiz-Antorán, Belén, et al.
Publicado: (2020)

Letter to Editor Regarding the OCEAN Study [Letter]
por: Yawn, Barbara P, et al.
Publicado: (2021)

Letter to the Editor Regarding Vaping Article
por: Spitz, Rabbi Yehuda
Publicado: (2019)

Response letter regarding the letter to the editors by Brown et al.
por: Taylor, Sylvia, et al.
Publicado: (2016)

Letter to the editor: Regarding the editorial by Penttinen and Friede
por: Fry, Alicia M, et al.
Publicado: (2016)

Letter to the Editor Regarding “Letter to the Editor: Spinal and Neurosurgical Publications During the COVID-19 Era”
por: Akhaddar, Ali, et al.
Publicado: (2020)

Letter to Editor: Support to the Spanish language, from Oral Medicine
por: Chimenos-Küstner, Eduardo
Publicado: (2017)

Letter to the editor regarding “The efficacy and safety of infliximab and calcineurin inhibitors in steroid-refractory UC patients: A meta-analysis”
por: Zhu, Qingcheng, et al.
Publicado: (2022)

Letter to the Editor Regarding: A Comprehensive Review on Copemyl(®)
por: Comi, Giancarlo, et al.
Publicado: (2018)

Letter to the editor regarding “Rotavirus infection beyond the gut”
por: Orrico-Sánchez, Alejandro, et al.
Publicado: (2019)

Letter to the Editor: Regarding “The Role of Obesity in Pediatric Orthopedics”
por: Rehm, Andreas, et al.
Publicado: (2020)

Letter to the editor regarding the paper “Tick infestation of the eyelid”
por: Dantas-Torres, Filipe
Publicado: (2020)

Letter to the Editor: Regarding COVID-19 in Children with Asthma
por: Özdemir, Öner
Publicado: (2021)

Letter to the editor regarding the article of Chen et al.
por: Islamoglu, Mehmet Sami, et al.
Publicado: (2022)

Letter to the Editor Regarding “Ultrasound Features of Adhesive Capsulitis”
por: Boudier-Revéret, Mathieu, et al.
Publicado: (2022)

Letter to the editor regarding “Selfies: A boon or bane?”
por: Kazerooni, Rashid
Publicado: (2022)

Letter to the Editor Regarding: Evolving Business Models in Orthotics
por: Laakso, L.
Publicado: (2022)

Letter to the editor regarding “unusual extraneural metastasis of glioblastoma”
por: Waack, Andrew Leland, et al.
Publicado: (2023)

Letter to Editor regarding “Unusual Presentation of Spontaneous Chylothorax”
por: Varghese, Anjali Rachel, et al.
Publicado: (2022)

Letter to the Editor Regarding Efficacy and Safety of Diclofenac and Capsaicin Gel in Patients with Acute Back/Neck Pain: A Multicenter Randomized Controlled Study
por: Schwartz, Ruben, et al.
Publicado: (2020)

A Response to: Letter to the Editor regarding “Influences of Gender on Intravenous Nalbuphine Actions After Major Abdominal Surgery: A Multicenter Study”
por: Ayad, Amany E., et al.
Publicado: (2021)

Reply to Letter to the Editor: Regarding “The Role of Obesity in Pediatric Orthopedics”
por: Nowicki, Philip, et al.
Publicado: (2020)

Letter to the editor regarding “disparities in telemedicine during COVID‐19”
por: De, Brian, et al.
Publicado: (2022)

Letter to the Editor Regarding “Blue Light Exposure: Ocular Hazards and Prevention—A Narrative Review”
por: Iqbal, Mohammed, et al.
Publicado: (2023)

Letter to the Editor regarding “Influences of Gender on Intravenous Nalbuphine Actions After Major Abdominal Surgery: A Multicenter Study”
por: Xue, Fu S., et al.
Publicado: (2021)

Letter to the editor
por: Rampal, Upamanyu, et al.
Publicado: (2018)

Letter to the Editor: Use of some inappropriate terms in Spanish in Oral Medicine and Pathology
por: Aguirre-Urizar, José-Manuel, et al.
Publicado: (2016)

Response to letter to the editor
por: Sridharan, Aadhavi, et al.
Publicado: (2022)

Letter to the Editor Regarding the Article, “Lithium in Late-Life Mania: A Systematic Review” [Letter]
por: Shah, Kaushal, et al.
Publicado: (2021)

Letter to the Editor: Regarding “The Utility and Limitations of FRAX: A US Perspective”
por: Czerwinski, Edward
Publicado: (2012)

Letter to editor regarding “comparison of efficacy of haloperidol and olanzapine in the treatment of delirium”
por: Kumar, Pawan, et al.
Publicado: (2019)

Authors’ Response to the Letter to the Editor Regarding: A Comprehensive Review on Copemyl(®)
por: Annovazzi, Pietro, et al.
Publicado: (2018)

Reply to the Letter to Editor Regarding “An Unusual Case of Critical Illness Polyneuromyopathy”
por: Mahashabde, Madhulika, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8lj3dk0r1esifu5llf81qumtid